La vendita allo scoperto per Laird Superfood dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Laird Superfood. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Laird Superfood (AMEX:LSF) Azioni, Report sulle vendite allo scoperto

Laird Superfood

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Laird Superfood Inc

LIFESTORE FINCL GRP INC by Lifestore Financial Group, Inc.

Lifestore Financial Group Inc

<p>HC Wainwright &amp; Co.  analyst Edward White   maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.</p>


News

Price Target

Analyst Ratings

AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

<p>The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.</p>


CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.</p>


Reiteration

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

<p>The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.</p>


BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

<p>Needham  analyst Ami Fadia   reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.</p>


NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

<p>Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.</p>
<p>With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.</p>
<p>&nbsp;</p>


Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

<p>Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year.  The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent.  This is a 0.54 percent increase over sales of $1.86 billion the same period last year.</p>


Earnings

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

<p>HC Wainwright &amp; Co.  analyst Patrick Trucchio   reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.</p>


ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

<p>Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent.  The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent.  This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.</p>


Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

<p>HC Wainwright &amp; Co.  analyst Amit Dayal   reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.</p>


GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

<p>Needham  analyst Ami Fadia   reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.</p>


Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

<p>Needham  analyst Mayank Tandon   maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.</p>


Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

<p>Needham  analyst Kyle Peterson   reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $350 price target.</p>


Needham Reiterates Buy on Equifax, Maintains $350 Price Target

<p>Needham  analyst Mike Matson   downgrades Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) from Buy to Hold and maintains the price target from $86 to $86.</p>


Downgrades

Needham Downgrades Boston Scientific to Hold, Maintains Price Target to $86

Laird Superfood (LSF) just unveiled an announcement. At the Company's Annual Meeting held on June 27, 2024, with over 68% of shares voting, shareho...

Laird Superfood Shareholders Back Board and Auditor Choices

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>If you&rsquo;re looking for vegan stocks to buy now, these picks are solid bets. </p>



<p>Vegan stocks are all the rage in recent years as people become more concerned about the environment, animal welfare and healthier lifestyles. </p>



<p>More folks are paying more attention to climate change and the benefits of plant-based diets. This has led to more investors jumping on the bandwagon of food companies prioritizing sustainability, cruelty-free practices and innovative plant-based products.</p>



<p>CEO of VegTech Invest Elysabeth Alfano <a href="https://foodinstitute.com/focus/lead-with-delicious-how-plant-based-thrives/">said recently</a> the growth of plant-based proteins is set to become a major financial opportunity for businesses and investors in the coming years.</p>



<p>And <span><a href="https://www.bccresearch.com/market-research/food-and-beverage/global-vegan-food-market.html#:~:text=Report%20Highlights,the%20period%20of%202022%2D2027.">the data</a></span> bears it out. In 2021, the global vegan food market was worth $35.6 billion and was projected to rise from $40.1 billion in 2022 to $91.9 billion by 2027. That&rsquo;s an annual growth rate of 18.1%.</p>



<p>Here are the three best vegan stock options to buy for Q3 of 2024.</p>



<h2>Ingredion (INGR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/11/ingredion-ingr-1600-300x169.jpg" alt="Ingredion Canada Inc head office in Brampton, Ontario, Canada"><div>Source: JHVEPhoto / Shutterstock.com</div></div><p>The <strong>Ingredion</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/ingr-stock-quote/"><strong>INGR</strong></a></span>) company&rsquo;s specialty for a long time has been sweeteners, starches, nutritional ingredients and biomaterials that go to&nbsp;food, beverages, paper and pharmaceuticals. But it has also recently forayed into a fully-fledged vegan line of products, especially meat alternatives made out of plant-based proteins.&nbsp;</p>



<p>Ingredion has several strengths going for it that make it one of the best vegan stocks to buy now. Though it posted below expectations for its revenue <a href="https://finance.yahoo.com/news/ingredion-inc-ingr-q1-2024-113213461.html#:~:text=Financial%20Performance%20Insights&amp;text=However%2C%20the%20adjusted%20EPS%20was,weather%20conditions%20and%20higher%20costs.">last quarter,</a> it topped analyst forecasts of $2.03 and registered earnings per share of $2.08. Also, Ingredion&rsquo;s share price has returned over 10% this year, pointing to a positive market sentiment.&nbsp;</p>



<p>Though those performances alone may not make a particularly strong thesis to invest in the firm, investors looking for more reasons to stake their money in Ingredion will be happy to know analysts have a <a href="https://www.marketwatch.com/investing/stock/ingr/analystestimates?mod=mw_quote_analyst">positive outlook</a> on the company&rsquo;s future prospects.</p>



<h2>Laird Superfood (LSF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/lsf-stock-1-300x169.jpg" alt="A display of Peruvian ground coffee from Laird Superfood (LSF)."><div>Source: David Tonelson / Shutterstock.com</div></div><p><strong>Laird Superfood</strong> (NYSEAMERICAN:<span><a href="https://investorplace.com/stock-quotes/lsf-stock-quote/"><strong>LSF</strong></a></span>) opened the year <a href="https://finance.yahoo.com/quote/LSF/history/">trading at</a> around $0.95. Shares for the plant-based foods company are now changing hands for an average of $4 &mdash; marking a jump of over 300% year-to-date (YTD).</p>



<p>The company owes this performance to its last quarter&rsquo;s earnings report. The company&rsquo;s metrics painted the picture of a company with particularly strong fundamentals.</p>



<p>For instance, its net sales <a href="https://investors.lairdsuperfood.com/news/news-details/2024/Laird-Superfood-Reports-First-Quarter-2024-Financial-Results/default.aspx">increased by</a> 22%, with net loss improving by $3.1 million. The company also raised its full-year guidance to $38-$42 million and projected a gross margin of 37%-41%. Its balance sheet is also strong, with zero debt.&nbsp;</p>



<p>Though it doesn&rsquo;t seem to be on the radar for a lot of investment firms, Laird Superfood nevertheless has received a Strong Buy rating for the two recommendations it has <a href="https://www.marketwatch.com/investing/stock/lsf/analystestimates?mod=mw_quote_analyst">on MarketWatch.</a> It&rsquo;s hands-down one of the best picks you can make for vegan stocks to buy now.</p>



<h2>Bunge Global (BG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/10/bunge_bg_1600-300x169.jpg" alt="A Photo of a blue sign in an industrial campus showing the Bunge (BG) logo."><div>Source: JHVEPhoto/ShutterStock.com</div></div><p>Although it&rsquo;s not a purely vegan food company, <strong>Bunge Global</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/bg-stock-quote/"><strong>BG</strong></a></span>), an agribusiness and food processing company, has been making a play in the vegan industry.&nbsp;Last year, the company <a href="https://vegconomist.com/agriculture-agribusiness/bunge-500m-soy-processing-facility/">rolled out</a> a $500 million soybean processing facility that will be ready by 2025 and will process an extra 4.5 million bushels of soybeans.</p>



<p>And this February, the company launched Beleaf PlantBetter &mdash; a plant-based alternative to traditional butter, expanding on its vegan foods portfolio.</p>



<p>Despite falling <a href="https://www.barrons.com/articles/bunge-stock-earnings-first-quarter-4699c0fb">short of expectations</a> by posting a smaller-than-expected drop in first-quarter profits and maintaining its 2024 outlook for annual adjusted earnings at $9 per share, down from $13.66 last year, the company&rsquo;s share price still surged by over 11% YTD.&nbsp;</p>



<p>Also, Bunge has favorable <a href="https://www.marketwatch.com/investing/stock/bg/analystestimates?mod=mw_quote_analyst">analyst ratings,</a> which is telling of its near future potential. Out of 11 analysts, 6 rated it a Buy, with 2 and 3 giving it Overweight and Hold recommendations, respectively. It&rsquo;s definitely one of the most promising choices for vegan stocks to buy now.</p>



<p><em>On the date of publication, Hope Mutie did not have (either directly or indirectly) any positions in the stocks mentioned in this article. The opinions expressed in this article are those of the writer, subject to InvestorPlace.com&rsquo;s </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/#:~:text=InvestorPlace.com%20asks%20writers%20to,strive%20to%20link%20to%20it."><em>Publishing Guidelines.</em></a></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Hope Mutie is a writer who&rsquo;s enthusiastic about finance and crypto. At InvestorPlace, she keeps her finger on the pulse of the stock and crypto markets to create insightful and info-rich content to help investors navigate the market with confidence.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/3-vegan-stocks-to-buy-now-q3-edition/">3 Vegan Stocks to Buy Now: Q3 Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Vegan Stocks to Buy Now: Q3 Edition

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Investors have many reasons for investing in plant-based <a href="https://investorplace.com/industries/consumer-staples/food/">food stocks</a>. Whether they have a personal penchant for socially responsible investing or are just looking to make some cold hard cash in a burgeoning industry, there are many companies to consider.&nbsp;</p>



<p>But there are also a lot of ups and downs in the vegan-friendly and plant-based industries. Even one of the most recognizable names in the vegan meat industry, <strong>Beyond Meat</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/"><strong>BYND</strong></a>), has been down consistently over the last five years, with very few times of sustained value.</p>



<p>However, the overall sector&rsquo;s potential for growth remains robust, and plant-based stocks can yield significant returns. The plant-based food market value is currently at $46.7 billion and could expand to $96.6 billion by 2033. That&rsquo;s a compound annual growth rate (CAGR) of 8.4%. With such a positive outlook, investors could see their portfolios flourish with these plant-based food stocks.</p>



<h2>Laird Superfood (LSF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/lsf-stock-1-300x169.jpg" alt="A display of Peruvian ground coffee from Laird Superfood (LSF)."><div>Source: David Tonelson / Shutterstock.com</div></div><p>Founded in 2015, <strong>Laird Superfood </strong>(NYSEAMERICAN:<a href="https://investorplace.com/stock-quotes/lsf-stock-quote/"><strong>LSF</strong></a>) specializes in providing plant-based coffee creamers, hydration supplements and other foods. The stock topped out at $57 in 2020 but has since dropped dramatically. It is now trading at around $4 a share. However, <a href="https://finance.yahoo.com/news/laird-superfood-reports-first-quarter-200000267.html">recent quarterly results</a> prove that the company is back on the upswing.&nbsp;</p>



<p>&ldquo;After more than 18 months of executing a turnaround on our business, I am pleased to announce first quarter results that demonstrate the achievement of our growth and margin goals,&rdquo; said CEO Jason Vieth on a recent investor call. The company&rsquo;s 22% net sales growth during the first quarter was among the top results for any company in the food industry. The company saw at least a 40% gross margin. While the company still operates at a net loss, its balance sheet remains strong with no debt. The company raised its outlook for net sales thanks to the positive Q1 results.</p>



<p>LSF stock is affordable for investors looking to enter the vegan-friendly and plant-based food stocks segment. Laird Superfood has many potential growth opportunities on the horizon. Its wholesale channel now sells more than its direct-to-consumer business. It recently received a $32 million influx of funding from <strong>WeWork</strong>. All this combined means investing now could see great returns in the long term.</p>



<h2>SunOpta (STKL)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2017/03/stklmsn-300x165.jpg" alt=""><div>Source: Shutterstock</div></div><p><strong>SunOpta</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/stkl-stock-quote/"><strong>STKL</strong></a>) has been producing plant-based food and beverages for over 50 years. In the past three years, the company has committed over $200 million to <a href="https://investor.sunopta.com/news/news-details/2023/SunOpta-Opens-New-125-Million-Plant-Based-Beverage-Manufacturing-Facility-in-Texas/default.aspx">expanding production</a> capacity and reaching its goal of doubling its plant-based business by 2025.</p>



<p>Across the several segments the company operates in, there is a $22 billion addressable market. The company&rsquo;s nutritional beverages sector saw the largest year-over-year (YOY) growth at 20%. The company also partners with other major names in the food retail industry. These include <strong>Costco</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cost-stock-quote/"><strong>COST</strong></a></span>), <strong>Walmart</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/wmt-stock-quote/"><strong>WMT</strong></a></span>) and <strong>Target</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/tgt-stock-quote/"><strong>TGT</strong></a></span>). Partnering with big retail brands helps increase the exposure of its products and, in turn, generates higher sales volume.</p>



<p>STKL stock has had its ups and downs over the past five years but currently has a 93% upside. A recent expansion at its Modesto, Calif. facility will allow SunOpta to &ldquo;increase the amount of oat milk produced annually by more than 60%, meeting ongoing customer demand.&rdquo; The company&rsquo;s next quarterly results will be announced on August 7, and considering its <a href="https://s23.q4cdn.com/915258311/files/doc_financials/2024/q1/1Q24-SunOpta-Earnings-Press-Release.pdf">previous quarter</a> had several earnings beats and positively adjusted outlooks, now might be a good time for investors to get in on this plant-based food stock before it starts to rally.</p>



<h2>Tyson Foods (TSN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/tyson-foods-tsn-1600-300x169.png" alt="A package of Tyson Foods (TSN) chicken breasts."><div>Source: rblfmr / Shutterstock.com</div></div><p>One of the most well-known chicken brands in the U.S. may not seem like a good pick for a list of plant-based food stocks. For investors who want to feel good about investing in companies working toward making more plant-based options but don&rsquo;t want to gamble on a company solely focused on that sector, <strong>Tyson Foods</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/tsn-stock-quote/"><strong>TSN</strong></a>) is a good way to diversify.&nbsp;</p>



<p>Though down substantially over the last five years, TSN stock has seen a rally of 10% in the last 12 months and 6.5% year-to-date (YTD). In the previous five years, Tyson has been increasing its plant-based offerings through its brand, Raised and Rooted, and has 10 plant-based products. These include plant-based patties, ground meat substitutes, sausages and nuggets. As inflation dampens demand for meat as prices soar, Tyson&rsquo;s presence in the plant-based industry will give it a head start compared to its competitors.&nbsp;</p>



<p>Though there have been some <a href="https://www.arkansasbusiness.com/article/tyson-foods-financial-recovery-turning-the-tide-in-2024/">financial troubles</a> for the company in the last year or so, things are starting to turn around. The company began fiscal 2024 with two steady quarters. CEO Donnie King recently shared his optimistic outlook at an investor conference in May. &ldquo;The first half of this year, we are fundamentally a stronger company.&rdquo; </p>



<p>Third-quarter financial results for Tyson Foods will be released in August. If management&rsquo;s optimism is to be believed, buying TSN now could generate a nice profit when the newest results come out shortly.&nbsp;</p>



<p><em>On&nbsp;the&nbsp;date&nbsp;of publication, Philippa Main&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in&nbsp;this&nbsp;article.&nbsp;The opinions expressed in&nbsp;this&nbsp;article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Philippa Main is a real estate agent in Virginia and Florida who also does freelance writing, editing, and business development and marketing. She uses her broad knowledge of the real estate market to inform her investing decisions in an array of different industries. She also enjoys working specifically with women to educate them about finance and investing.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
<p>The post <a href="https://investorplace.com/2024/07/3-plant-based-food-stocks-that-could-be-multibaggers-in-the-making-july-edition/">3 Plant-Based Food Stocks That Could Be Multibaggers in the Making: July Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Plant-Based Food Stocks That Could Be Multibaggers in the Making: July Edition

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Laird Superfood (LSF – Research Report) and Be...

Analysts' Opinions Are Mixed on These Consumer Goods Stocks: Laird Superfood (LSF) and BellRing Brands (BRBR)

Laird Superfood, Inc. (LSF) Q2 2024 Earnings Call Transcript

In a report released today, George Kelly from Roth MKM reiterated a Buy rating on Laird Superfood (LSF – Research Report), with a price target of $...

Roth MKM Keeps Their Buy Rating on Laird Superfood (LSF)

An update from Laird Superfood (LSF) is now available. Laird Superfood, Inc. has released its Q2 2024 Investor Presentation, providing shareholders...

Laird Superfood Unveils Q2 2024 Financial Insights

These food stocks are on the move after Mars' sector-rattling deal for Kellanova

Sow Good Has Little Social Media Presence And Doesn't Make Its Own Candy - Sell The Freeze-Dried Hype

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Buy rating on Laird Superfood (LSF – Research Report). The company's shares...

Comments

Laird Superfood

Vendite allo scoperto

Laird Superfood (AMEX:LSF) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO